Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hologic, Inc. (HOLX : NSDQ)
 
 • Company Description   
Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Number of Employees: 6,705

 
 • Price / Volume Information   
Yesterday's Closing Price: $77.75 Daily Weekly Monthly
20 Day Moving Average: 2,242,715 shares
Shares Outstanding: 249.38 (millions)
Market Capitalization: $19,389.37 (millions)
Beta: 1.09
52 Week High: $81.04
52 Week Low: $60.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.88% 13.61%
12 Week 9.34% 20.19%
Year To Date 1.55% 24.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
250 CAMPUS DRIVE
-
MARLBOROUGH,MA 01752
USA
ph: 508-263-2900
fax: 781-890-8031
ryan.simon@hologic.com http://www.hologic.com
 
 • General Corporate Information   
Officers
STEPHEN P. MACMILLAN - Chief Executive Officer; Chairman and President
KARLEEN M. OBERTON - Chief Financial Officer
BENJAMIN J. COHN - Vice President; Corporate Controller
SALLY W. CRAWFORD - Lead Independent Director
CHARLES DOCKENDORFF - Director

Peer Information
Hologic, Inc. (ABMD)
Hologic, Inc. (DMDS)
Hologic, Inc. (CPWY.)
Hologic, Inc. (EQUR)
Hologic, Inc. (ECIA)
Hologic, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 436440101
SIC: 3844
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 249.38
Most Recent Split Date: 4.00 (2.00:1)
Beta: 1.09
Market Capitalization: $19,389.37 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.70 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $5.56 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 14.40% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.99
Trailing 12 Months: 10.83
PEG Ratio: 0.97
Price Ratios
Price/Book: 4.05
Price/Cash Flow: 7.61
Price / Sales: 3.60
EPS Growth
vs. Year Ago Period: -20.08%
vs. Previous Quarter: -4.61%
Sales Growth
vs. Year Ago Period: -6.63%
vs. Previous Quarter: -2.41%
ROE
03/31/22 - 42.26
12/31/21 - 48.46
09/30/21 - 57.61
ROA
03/31/22 - 20.26
12/31/21 - 22.83
09/30/21 - 26.38
Current Ratio
03/31/22 - 2.97
12/31/21 - 2.74
09/30/21 - 2.39
Quick Ratio
03/31/22 - 2.57
12/31/21 - 2.34
09/30/21 - 2.01
Operating Margin
03/31/22 - 34.11
12/31/21 - 36.19
09/30/21 - 38.77
Net Margin
03/31/22 - 28.79
12/31/21 - 31.23
09/30/21 - 33.22
Pre-Tax Margin
03/31/22 - 36.06
12/31/21 - 39.15
09/30/21 - 41.92
Book Value
03/31/22 - 19.22
12/31/21 - 18.08
09/30/21 - 16.64
Inventory Turnover
03/31/22 - 3.77
12/31/21 - 3.82
09/30/21 - 3.91
Debt-to-Equity
03/31/22 - 0.59
12/31/21 - 0.63
09/30/21 - 0.65
Debt-to-Capital
03/31/22 - 37.15
12/31/21 - 38.60
09/30/21 - 39.33
 

Powered by Zacks Investment Research ©